The Pathology of Amyloidosis in Classification: A Review

@article{Picken2020ThePO,
  title={The Pathology of Amyloidosis in Classification: A Review},
  author={Maria M Picken},
  journal={Acta Haematologica},
  year={2020},
  volume={143},
  pages={322 - 334}
}
  • M. Picken
  • Published 11 May 2020
  • Medicine, Biology
  • Acta Haematologica
Background: The amyloidoses are a rare and heterogeneous group of disorders that are characterized by the deposition of abnormally folded proteins in tissues ultimately leading to organ damage. The deposits are mainly extracellular and are recognizable by their affinity for Congo red and their yellow-green birefringence under polarized light. Current classification of amyloid in medical practice is based on the amyloid protein type. To date, 36 proteins have been identified as being… 

Figures and Tables from this paper

Diagnosis of amyloid beyond Congo red.
  • M. Picken
  • Medicine, Biology
    Current opinion in nephrology and hypertension
  • 2020
TLDR
Despite significant advances in the treatment of the systemic amyloidoses, outcomes remain poor, primarily due to delays in diagnosis, and Precise diagnosis of the amyloids protein type is critical for treatment selection.
LECT-2 amyloidosis: what do we know?
TLDR
A renal biopsy along with characteristic features found on immunohistochemistry and mass spectrometry is diagnostic of ALECT2, a novel form of amyloidosis derived from leukocyte chemotactic factor 2 (LECT-2) primarily involving the kidneys that can form amyloids deposits even in its unmutated form.
Diagnosis of Amyloidosis: From History to Current Tools
TLDR
This fascinating protein from a clinical diagnosis perspective is discussed, in the course of the current chapter, and varying modalities with increasing complexity, such as immunohistochemistry, electron microscopy, and mass spectrometry need to be employed.
Amyloidosis from the patient perspective: the French daily impact of amyloidosis study.
  • T. Damy, D. Adams, S. Georgin-lavialle
  • Medicine, Psychology
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
  • 2022
TLDR
The patient burden according to the main types of systemic amyloidosis needs to be analysed to optimise patient benefits and reduce the delay to confirmed amyloidsosis diagnosis.
Menorrhagia due to uterine amyloidosis in familial Mediterranean fever: case-based review
TLDR
A 40-year-old female patient with FMF known for 38 years who underwent splenectomy and hysterectomy is presented, first-of-its-kind to describe FMF-associated uterine AA amyloidosis and a discussion of possible mechanisms of amyloidsosis-induced uterine bleeding is provided.
Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
TLDR
It is shown that cell-derived EVs are involved in the formation of TTR amyloid deposits on the membrane of small EVs, as well as the deposition of T transthyretin in cells, and that TTR in serum-derived small EVs is a potential target for future ATTRv amyloidsosis diagnosis and therapy.
A systemic apolipoprotein A-IV-associated amyloidosis confirmed by proteome analysis
TLDR
A case of systemic apolipoprotein A-IV-associated amyloidosis that was confirmed by proteome analysis using formalin-fixed paraffin-embedded tissue and an immunohistochemical technique is reported.
Localized Amyloidosis of the Nasal Mucosa: A Case Report and Review of the Literature
TLDR
Localized sinonasal amyloidosis has a good prognosis and surgical resection should be selected as a first-line treatment; however, clinicians should recognize the high probability of recurrence.
A stepwise data interpretation process for renal amyloidosis typing by LMD-MS
TLDR
The proteomic data interpretation procedure for LMD-MS based amyloidosis typing was established successfully that has a high practicability in clinical application and might be an alternative indicator for amyloidsosis diagnosis.
...
...

References

SHOWING 1-10 OF 103 REFERENCES
Localized Amyloidoses and Amyloidoses Associated with Aging Outside the Central Nervous System
TLDR
There is increasing evidence that IAPP, either as mature amyloid fibrils or as prefibrillar aggregates, is toxic to islet β-cells and plays an important role in the pathogenesis of type 2 diabetes.
Proteomics and mass spectrometry in the diagnosis of renal amyloidosis
TLDR
The current recommendations for the application of proteomics in renal amyloidosis are summarized and the advantages as well as the limitations of both methods—immunohistochemistry and MS-based proteomics—are discussed.
Systemic amyloidosis
Fibrinogen alpha amyloidosis: insights from proteomics
TLDR
A combination of expert pathologist review, mass spectrometry, and gene sequencing can allow for confident diagnosis and determination of the fibrinogen alpha chain mutated sequence.
The hereditary amyloidoses.
  • M. Benson
  • Medicine, Biology
    Best practice & research. Clinical rheumatology
  • 2003
Amyloidosis: Insights from Proteomics.
  • A. Dogan
  • Biology, Medicine
    Annual review of pathology
  • 2017
TLDR
Application of mass spectrometry-based proteomic technologies for analysis of amyloid plaques has transformed the way amyloidsosis is diagnosed and classified, and led to identification of numerous newAmyloid types, including ALECT2 amyloidalosis, which is now recognized as one of the most common causes of systemic ameloidosis in North America.
Sensitive and reliable immunohistochemical typing of 21 different amyloid classes in 782 patients using amyloid-type specific antibodies directed against the amyloidotic conformation. With comments on the gold standard debate
  • R. Linke, A. Meinel, J. Chalcroft
  • Biology, Medicine
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
  • 2017
TLDR
Three different modes of typings are in use, the two commonly known ones being immunohistochemistry (IHC) and mass-spectrometry (M-S) and a third is used in the field but rarely cited, since it involves expert microscopic pathomorphologic observation of special amyloids, so typical that they can easily be visually recognized.
Modern Approaches to the Treatment of Amyloidosis: The Critical Importance of Early Detection in Surgical Pathology
  • M. Picken
  • Medicine
    Advances in anatomic pathology
  • 2013
TLDR
This review provides an update on pathogenesis, the clinical and pathologic features, and treatments of various amyloidoses, as well as the current terminology, classification, and practical considerations that are relevant to the diagnosis.
Systemic amyloidosis: novel therapies and role of biomarkers.
  • M. Nuvolone, G. Merlini
  • Biology, Medicine
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2017
TLDR
Improved diagnostic and imaging approaches and the increasing role of biomarkers have considerably improved the management of systemic amyloidosis, and recent, substantial improvements in the understanding of the molecular underpinnings have unveiled different key steps in the amyloidsogenic cascade which can be valid therapeutic targets.
Pathology and diagnosis of renal non-AL amyloidosis
TLDR
Non-AL amyloidosis is a group of amyloidsosis with distinctive clinical, laboratory and renal pathology findings, based on finding the signature amyloidal peptides, apolipoprotein E and serum isyloid-P component, followed by detection of precursor amylidogenic protein such as LECT2, fibrinogen-α, gelsolin, etc.
...
...